Statistics

Total Visits

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study61

Select a period of time:

Number of views in the range

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study19

Views

Views
November 20255
December 20250
January 20260
February 20260
March 20263
April 20268
May 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
United Kingdom3
Australia1
Brazil1
Spain1
Finland1
Kenya1
Mexico1
Venezuela1
 

Top cities views

Views
Piscataway2
Council Bluffs2
Ciudad Juárez1
Dallas1
Harrisburg1
Helsinki1
Los Angeles1
Madrid1
Marsabit1
New York1